The stock of Doximity Inc (DOCS) has seen a 3.24% increase in the past week, with a 3.89% gain in the past month, and a 33.50% flourish in the past quarter. The volatility ratio for the week is 3.22%, and the volatility levels for the past 30 days are at 3.83% for DOCS. The simple moving average for the last 20 days is 3.14% for DOCS stock, with a simple moving average of 56.05% for the last 200 days.
Is It Worth Investing in Doximity Inc (NYSE: DOCS) Right Now?
Doximity Inc (NYSE: DOCS) has a higher price-to-earnings ratio of 62.40x compared to its average ratio, The 36-month beta value for DOCS is at 1.40. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 2 rating it as “overweight,” 12 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for DOCS is 123.70M, and currently, shorts hold a 6.00% of that float. The average trading volume for DOCS on December 18, 2024 was 1.81M shares.
DOCS) stock’s latest price update
Doximity Inc (NYSE: DOCS)’s stock price has increased by 2.92 compared to its previous closing price of 52.70. However, the company has seen a 3.24% increase in its stock price over the last five trading sessions. businesswire.com reported 2024-12-17 that SAN FRANCISCO–(BUSINESS WIRE)–Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its State of Telemedicine Report, showing that 83% of physician telemedicine users surveyed would like virtual care to remain a permanent part of their clinical practice. Among physicians surveyed, 84% highlighted telemedicine’s value in improving continuity of care for patients with chronic or complex conditions, and 96% emphasized its role as a complement to.
Analysts’ Opinion of DOCS
Many brokerage firms have already submitted their reports for DOCS stocks, with Mizuho repeating the rating for DOCS by listing it as a “Neutral.” The predicted price for DOCS in the upcoming period, according to Mizuho is $55 based on the research report published on December 04, 2024 of the current year 2024.
Goldman, on the other hand, stated in their research note that they expect to see DOCS reach a price target of $58. The rating they have provided for DOCS stocks is “Neutral” according to the report published on November 15th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to DOCS, setting the target price at $53 in the report published on November 14th of the current year.
DOCS Trading at 11.98% from the 50-Day Moving Average
After a stumble in the market that brought DOCS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.16% of loss for the given period.
Volatility was left at 3.83%, however, over the last 30 days, the volatility rate increased by 3.22%, as shares surge +5.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +22.67% upper at present.
During the last 5 trading sessions, DOCS rose by +3.52%, which changed the moving average for the period of 200-days by +96.07% in comparison to the 20-day moving average, which settled at $52.60. In addition, Doximity Inc saw 93.44% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DOCS starting from Bryson Anna, who sale 100,000 shares at the price of $58.42 back on Nov 12 ’24. After this action, Bryson Anna now owns 304,506 shares of Doximity Inc, valued at $5,842,248 using the latest closing price.
Bryson Anna, the Officer of Doximity Inc, proposed sale 70,000 shares at $60.00 during a trade that took place back on Nov 12 ’24, which means that Bryson Anna is holding shares at $4,200,000 based on the most recent closing price.
Stock Fundamentals for DOCS
Current profitability levels for the company are sitting at:
- 0.39 for the present operating margin
- 0.9 for the gross margin
The net margin for Doximity Inc stands at 0.34. The total capital return value is set at 0.2. Equity return is now at value 19.00, with 16.24 for asset returns.
Based on Doximity Inc (DOCS), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at 29.24.
Currently, EBITDA for the company is 182.08 million with net debt to EBITDA at -0.8. When we switch over and look at the enterprise to sales, we see a ratio of 19.21. The receivables turnover for the company is 4.14for trailing twelve months and the total asset turnover is 0.46. The liquidity ratio also appears to be rather interesting for investors as it stands at 7.21.
Conclusion
In conclusion, Doximity Inc (DOCS) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
